59.18
0.29 (0.49%)
| Previous Close | 58.89 |
| Open | 58.75 |
| Volume | 1,177,509 |
| Avg. Volume (3M) | 1,542,314 |
| Market Cap | 8,011,729,920 |
| Price / Earnings (TTM) | 44.16 |
| Price / Earnings (Forward) | 15.75 |
| Price / Sales | 3.05 |
| Price / Book | 1.82 |
| 52 Weeks Range | |
| Earnings Date | 5 Aug 2025 |
| Profit Margin | 7.39% |
| Operating Margin (TTM) | 16.43% |
| Diluted EPS (TTM) | 1.34 |
| Quarterly Revenue Growth (YOY) | -1.40% |
| Quarterly Earnings Growth (YOY) | 76.30% |
| Total Debt/Equity (MRQ) | 2.27% |
| Current Ratio (MRQ) | 4.45 |
| Operating Cash Flow (TTM) | 645.55 M |
| Levered Free Cash Flow (TTM) | 636.51 M |
| Return on Assets (TTM) | 5.84% |
| Return on Equity (TTM) | 4.63% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | Globus Medical, Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | 3.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | 1.88 |
|
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 0.69% |
| % Held by Institutions | 100.63% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 90.00 (Canaccord Genuity, 52.08%) | Buy |
| Median | 68.00 (14.90%) | |
| Low | 66.00 (Wells Fargo, 11.52%) | Buy |
| Average | 74.67 (26.17%) | |
| Total | 3 Buy | |
| Avg. Price @ Call | 55.84 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Wells Fargo | 08 Aug 2025 | 66.00 (11.52%) | Buy | 58.65 |
| Canaccord Genuity | 22 Jul 2025 | 90.00 (52.08%) | Buy | 53.01 |
| Morgan Stanley | 15 Jul 2025 | 68.00 (14.90%) | Buy | 55.87 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 28 Aug 2025 | Announcement | Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc. |
| 07 Aug 2025 | Announcement | Globus Medical Reports Second Quarter 2025 Results |
| 21 Jul 2025 | Announcement | Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results |
| 21 Jul 2025 | Announcement | Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer |
| 17 Jul 2025 | Announcement | Globus Medical Schedules Second Quarter Earnings Release and Conference Call |
| 15 Jul 2025 | Announcement | Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |